REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Immedica Pharma Polska Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Merchant Wholesalers, Durable Goods | Machinery, Equipment, and Supplies Merchant Wholesalers | Other Miscellaneous Durable Goods Merchant Wholesalers | Rental and Leasing Services | Scientific Research and Development Services | All Other Professional, Scientific, and Technical Services | Professional Organizations
Full name: Immedica Pharma Polska Sp. z o.o. Profile Updated: May 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Immedica Pharma Polska Sp. z o.o. is a company based in Poland, with its head office in Warsaw. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The enterprise was incorporated on February 08, 2019. In 2023, the company reported a net sales revenue increase of 7.97%. Its’ total assets recorded a growth of 26.63%. In 2023, Immedica Pharma Polska Sp. z o.o.’s net profit margin decreased by 0.8%.

Headquarters
Ul. Bagatela 3
Warsaw; Mazowieckie; Postal Code: 00-585

Contact Details: Purchase the Immedica Pharma Polska Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Immedica Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Immedica Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
February 08, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Immedica Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
7.97%▲
Total operating revenue
7.98%▲
Operating profit (EBIT)
4.73%▲
Net Profit (Loss) for the Period
-6.31%▼
Total assets
26.63%▲
Total equity
18.61%▲
Operating Profit Margin (ROS)
-0.21%▼
Net Profit Margin
-0.8%▼
Return on Equity (ROE)
-4.18%▼
Quick Ratio
-0.21%▼
Cash Ratio
0.2%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo